Renaissance Technologies »

Acrivon Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 623k 1.81
2025-06-30 $606k 509k 1.19
2025-03-31 $106k 52k 2.03
2024-12-31 $297k 49k 6.02
2024-09-30 $321k 46k 7.00
2024-06-30 $316k 55k 5.80
2024-03-31 $734k 103k 7.15